This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). Its structure makes it a valuable intermediate in the creation of drugs targeting central nervous system disorders, such as depression, anxiety, and other neurological conditions. Additionally, it is employed in the study of serotonin and dopamine receptor activity, aiding in the development of novel therapeutic agents. Its chiral nature also allows for the exploration of enantiomer-specific pharmacological effects, enhancing drug efficacy and safety profiles.